Why Your Body Destroys NAD+ Before It Can Use It (And the $5 Fix Nobody Talks About)

Your body cannot use NAD+ directly. The molecule is too large to pass through a cell membrane, so the moment you swallow an NAD+ supplement or receive it through an IV, your body immediately breaks it apart outside the cell and then rebuilds it from the pieces on the inside. That is not a flaw in the system. That is how the system was designed to work.

Understanding that one fact changes everything about how you think about NAD+ supplementation.

Here is the full chain before we zoom into any single part of it. NAD+ breaks down outside the cell into smaller precursor molecules. Those precursors enter the cell through specific transporters. Once inside, the cell runs them through a recycling process called the salvage pathway, which is essentially a rebuild sequence that reassembles NAD+ from its components. The finished NAD+ then powers your mitochondria, fuels your DNA repair enzymes, and drives dozens of other metabolic reactions. That is the whole map.

Now here is where most people's understanding of NAD+ supplementation goes wrong.

When you take NMN, which is a popular and expensive precursor, most people assume it enters the cell directly and gets converted there. But a 2016 study in Nature Communications found that NMN cannot actually enter most mammalian cells as NMN. It first has to be converted to something called NR, which stands for nicotinamide riboside, by an enzyme called CD73 that sits on the outside of the cell membrane. NR is the actual molecule that gets transported in. So NMN is really just a way to deliver NR, which means whether you are taking NMN or taking NR directly, both molecules end up at the same front door waiting to get inside.

That front door is the salvage pathway.

The salvage pathway is the main recycling system your cells use to keep NAD+ levels stable, and it works reasonably well when you are young. The problem is there is an enzyme called CD38 that also breaks down NAD+, and it does not stay constant as you age. A 2016 study in Cell Metabolism found that CD38 activity increases two to three fold across tissues as you get older, and the inverse correlation between CD38 activity and NAD+ levels was nearly perfect in that data. More CD38 means less NAD+, and the older you get, the more CD38 you have.

So you are taking an expensive precursor, it is funneling into the salvage pathway, and the salvage pathway is increasingly congested because an age-driven enzyme is chewing through your NAD+ faster than the pathway can keep up. You are pouring water into a bucket that has a bigger and bigger hole in the bottom.

This is the part the supplement marketing does not explain.

But there is a second pathway that most people have never heard of, and it does not share this problem. It is called the Preiss-Handler pathway, and it uses a completely different entry point into NAD+ synthesis. Instead of going through NR and the salvage pathway, this route starts with niacin, which is just regular vitamin B3, and it runs through a separate series of enzymatic steps that produce NAD+ independently.

Because the Preiss-Handler pathway does not run through the same congested salvage system, CD38's activity does not block it the same way. You are using a different road entirely.

A 2020 study published in Cell Metabolism tested this directly in a group of patients with confirmed NAD+ deficiency caused by mitochondrial disease. These were people with genuinely depleted NAD+ levels, not healthy subjects with normal baseline readings. Over the course of the study, niacin at 750 to 1000 milligrams per day raised blood NAD+ by 2.3 times and raised muscle NAD+ by 1.3 times. Alongside those NAD+ increases, the researchers also observed improvements in muscle strength and markers of mitochondrial biogenesis, meaning the cells were not just showing higher NAD+ on paper but actually responding to it functionally.

The 2.3 times increase in blood NAD+ sits in the same range as what NMN and NR studies have reported in their best results, and niacin costs about five dollars a month at any pharmacy.

There is one more piece of this worth understanding, because a 2019 study in Cell Reports found something unexpected when looking at what happens to NR inside the body after you take it. When researchers measured the metabolic byproducts in human skeletal muscle after NR supplementation, they found significant increases in something called NAAD, which is an intermediate that belongs to the Preiss-Handler pathway, not the salvage pathway. NR was partially converting to nicotinic acid inside the body and then re-entering through the Preiss-Handler route anyway. In other words, even the expensive NR supplement was partly working by becoming niacin downstream.

The niacin flush is real and worth knowing about before you start. When you first take niacin at meaningful doses, your skin turns red and warm, sometimes itchy, for twenty to thirty minutes. This happens because niacin triggers a release of prostaglandins that dilate capillaries near the skin surface. It is not an allergic reaction and it is not harmful, but it is startling if you are not expecting it. Most people find it fades significantly within two weeks as the body adapts, and taking niacin with food or starting at a lower dose and building up can reduce the intensity early on.

The practical answer here is simpler than the supplement industry would prefer. If you are trying to raise NAD+ and you are not already taking niacin, starting there makes more sense than spending thirty to eighty dollars a month on NMN or NR that has to fight through a pathway that gets less efficient with every year you age.

The expensive molecules are not fake. The biology they target is real. But the biology also contains a second road, one that was there the whole time, built into your cells long before anyone was charging a premium to help you find it.

---

References

1. Ratajczak J, Joffraud M, Trammell SAJ, et al. 2016. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications, 7:13103. Finding: NMN must be converted to NR by CD73 before cellular uptake, establishing NR as the common entry point for both NMN and NR supplementation. Source
2. Elhassan YS, Kluckova K, Fletcher RS, et al. 2019. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports, 287:1717-1728. Finding: NR supplementation produced significant increases in NAAD a Preiss-Handler pathway intermediate in human muscle, indicating NR partially converts to nicotinic acid in vivo. Source
3. Pirinen E, Auranen M, Khan NA, et al. 2020. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metabolism, 316:1078-1090. Finding: Niacin 750-1000 mg/day raised blood NAD+ 2.3x and muscle NAD+ 1.3x in human subjects via the Preiss-Handler pathway, with concurrent improvements in muscle strength and mitochondrial biogenesis. Source
4. Grant R, Berg J, Mestayer R, et al. 2019. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11:257. Finding: IV NAD+ 750 mg was rapidly and completely removed from plasma, with metabolites confirming full extracellular degradation before cellular uptake. Source
5. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism, 236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across tissues, with near-perfect inverse correlation to NAD+ levels. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness